Loss of CD36 impairs hepatic insulin signaling by enhancing the interaction of PTP1B with IR
Open Access
- 25 February 2020
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 34 (4) , 5658-5672
Abstract
A contradictory role of CD36 in insulin resistance was found to be related to the nutrient state. Here, we examined that the physiological functions of CD36 in insulin signal transduction in mice fed a low‐fat diet. CD36 deficiency led to hepatic insulin resistance and decreased insulin‐stimulated tyrosine phosphorylation of insulin receptor β (IRβ) in mice fed a low‐fat diet. The ability of insulin to bind with IR did not differ between WT and CD36‐deficient hepatocytes. CD36 formed a complex with IRβ and dissociation of CD36/Fyn complex or inhibition of Fyn only partially reversed the effects of CD36 on hepatic insulin signaling. Furthermore, we found that CD36 deficiency led to abnormally increased hepatic protein‐tyrosine phosphatase 1B (PTP1B) expression and enhanced PTP1B and IR interactions, which contributed to the decreased insulin signaling and disordered glucose metabolism. In addition, increased endoplasmic reticulum (ER) stress was found in the livers of the CD36‐deficient mice, while inhibited ER stress normalized the PTP1B expression and restored insulin signaling in the CD36‐deficient mice. Our findings suggest that the loss of CD36 impairs hepatic insulin signaling by enhancing the PTP1B/IR interaction that is induced by ER stress, indicating a possible critical step in the progression of hepatic insulin resistance.Keywords
Funding Information
- National Natural Science Foundation of China (81873569, 31571210, 81400786)
This publication has 39 references indexed in Scilit:
- Protein Tyrosine Phosphatase 1B and Insulin Resistance: Role of Endoplasmic Reticulum Stress/Reactive Oxygen Species/Nuclear Factor Kappa B AxisPLOS ONE, 2013
- Scavenger Receptor CD36 Expression Contributes to Adipose Tissue Inflammation and Cell Death in Diet-Induced ObesityPLOS ONE, 2012
- CD36 genetics and the metabolic complications of obesityCurrent Opinion in Clinical Nutrition and Metabolic Care, 2011
- Pathogenic Role of Scavenger Receptor CD36 in the Metabolic Syndrome and DiabetesMetabolic Syndrome and Related Disorders, 2011
- Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis CGut, 2011
- Soluble CD36− a marker of the (pathophysiological) role of CD36 in the metabolic syndrome?Archives of Physiology and Biochemistry, 2011
- A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signallingCardiovascular Research, 2010
- CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and BehaviorScience Signaling, 2009
- CD36-Facilitated Fatty Acid Uptake Inhibits Leptin Production and Signaling in Adipose TissueDiabetes, 2007
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolismJournal of Clinical Investigation, 2001